Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Botanix Pharmaceuticals Limited (AU:BOT)
:BOT
Holding AU:BOT?
Track your performance easily
BOT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.16 - AU$0.51
Previous CloseN/A
Volume8.15M
Average Volume (3M)5.38M
Market Cap
AU$858.04M
Enterprise ValueAU$545.15M
Total Cash (Recent Filing)$5.72M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,825,627,100
10 Day Avg. Volume6,984,190
30 Day Avg. Volume5,377,251
Standard Deviation0.28
R-Squared0.21
Alpha0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.64
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Botanix Pharmaceuticals Limited News
PremiumCompany Announcements
Botanix Pharmaceuticals’ Chair Adjusts Shareholding Amidst Strategic Growth
PremiumCompany Announcements
Insignia Financial Reduces Stake in Botanix Pharmaceuticals
PremiumCompany Announcements
Botanix Pharmaceuticals Updates Director’s Shareholding
PremiumCompany Announcements
Botanix Pharmaceuticals Announces Quotation of New Securities
PremiumCompany Announcements
Botanix Pharmaceuticals Prepares for Sofdra™ Market Launch
PremiumCompany Announcements
Botanix Pharmaceuticals: Director’s Stock Interests SurgeOptions Prices
Currently, No data available
---
Ownership Overview
1.03%
Insiders
― Other Institutional Investors
98.94% Public Companies and
Individual Investors
BOT FAQ
What was Botanix Pharmaceuticals Limited’s price range in the past 12 months?
Botanix Pharmaceuticals Limited lowest share price was AU$0.16 and its highest was AU$0.51 in the past 12 months.
What is Botanix Pharmaceuticals Limited’s market cap?
Botanix Pharmaceuticals Limited’s market cap is AU$858.04M.
When is Botanix Pharmaceuticals Limited’s upcoming earnings report date?
Botanix Pharmaceuticals Limited’s upcoming earnings report date is Feb 27, 2025 which is in 39 days.
How were Botanix Pharmaceuticals Limited’s earnings last quarter?
Botanix Pharmaceuticals Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Botanix Pharmaceuticals Limited overvalued?
According to Wall Street analysts Botanix Pharmaceuticals Limited’s price is currently Overvalued.
Does Botanix Pharmaceuticals Limited pay dividends?
Botanix Pharmaceuticals Limited does not currently pay dividends.
What is Botanix Pharmaceuticals Limited’s EPS estimate?
Botanix Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Botanix Pharmaceuticals Limited have?
Botanix Pharmaceuticals Limited has 1,825,627,100 shares outstanding.
What happened to Botanix Pharmaceuticals Limited’s price movement after its last earnings report?
Botanix Pharmaceuticals Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of Botanix Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in AU:BOT
---
Botanix Pharmaceuticals Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:BOT Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
161.11%
12-Months-Change
Fundamentals
Return on Equity
-21.07%
Trailing 12-Months
Asset Growth
352.83%
Trailing 12-Months
Company Description
Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.
---
Technical Analysis
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Arovella Therapeutics Limited
―
Noxopharm Ltd.
―
AnteoTech Ltd
―
---